CCM
CYT
CAAS Capital Management’s Cyteir Therapeutics, Inc. Common Stock CYT Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q1 | – | Sell |
-26,175
| Closed | -$79.6K | – | 381 |
|
|
2023
Q4 | $79.6K | Hold |
26,175
| – | – | 0.01% | 95 |
|
|
2023
Q3 | $74.3K | Sell |
26,175
-8,361
| -24% | -$23.7K | ﹤0.01% | 173 |
|
|
2023
Q2 | $89.8K | Sell |
34,536
-115,870
| -77% | -$301K | 0.01% | 157 |
|
|
2023
Q1 | $274K | Sell |
150,406
-309,373
| -67% | -$563K | 0.01% | 147 |
|
|
2022
Q4 | $759K | Sell |
459,779
-157,043
| -25% | -$259K | 0.05% | 92 |
|
|
2022
Q3 | $1.27M | Buy |
616,822
+536,938
| +672% | +$1.11M | 0.06% | 120 |
|
|
2022
Q2 | $239K | Sell |
79,884
-25,207
| -24% | -$75.4K | 0.01% | 293 |
|
|
2022
Q1 | $396K | Sell |
105,091
-372,419
| -78% | -$1.4M | 0.02% | 162 |
|
|
2021
Q4 | $5.43M | Sell |
477,510
-102,236
| -18% | -$1.16M | 0.13% | 52 |
|
|
2021
Q3 | $10.2M | Buy |
579,746
+79,746
| +16% | +$1.4M | 0.2% | 35 |
|
|
2021
Q2 | $10.7M | Buy |
+500,000
| New | +$10.7M | 0.18% | 43 |
|